1: (ROOT (NP (NP (NP (CD COVI-19)) (CC and) (NP (NN Lipoprotein))) (: :) (NP (NP (NP (NN Time)) (PP (IN for) (NP (NNP Widespread) (NN TestingArticle)))) (NP (NN courtesy) (PP (IN of) (: :) (NP (NP (NP (NNP D.) (NNP Joel) (NNP Kahn)) (, ,) (NP (NNP MD))) (, ,) (NP (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NN world) (POS 's)) (JJ top) (NNS cardiologists)))) (, ,) (NP (ADJP (JJS best) (VBG selling)) (NN author)) (, ,) (NP (NN lecturer)) (, ,) (NP (NP (NN expert)) (PP (IN in) (NP (NP (ADJP (NN plan) (HYPH -) (VBN based)) (NN nutrition)) (CC and) (NP (JJ holistic) (NN care)))))))))) (. .)))
2: (ROOT (S (NP (NN Lipoprotein)) (VP (VBZ is) (NP (DT a) (ADJP (RB still) (RB largely) (JJ unknown)) (NML (NNP LD) (HYPH -) (NN cholesterol)) (JJ like) (NN molecule))) (. .)))
3: (ROOT (S (NP (PRP It)) (VP (VBZ is) (, ,) (ADVP (RB however)) (, ,) (NP (NP (DT the) (ADJP (RBS most) (JJ frequent)) (VBN inherited) (NN risk) (NN factor)) (PP (IN for) (NP (NP (NN heart) (NN attack)) (, ,) (NP (NN stroke)) (, ,) (CC and) (NP (NML (JJ calcific) (JJ aortic) (NN valve)) (NN disease)))))) (. .)))
4: (ROOT (S (NP (NP (NN Lipoprotein)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NNP Lp)))) (, ,)) (VP (VBZ is) (VP (VBN inherited) (PP (IN in) (NP (NP (CD 2) (CD -) (CD 30) (NN %)) (PP (IN of) (NP (NP (NNS populations)) (VP (VBN tested)))))) (VP (VBG suggesting) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN elevated) (PP (IN in) (NP (NP (QP (RB over) (CD .5) (CD billion)) (NNS people)) (ADVP (RB worldwide))))))))))) (. .)))
5: (ROOT (S (S (NP (NP (NNS Reports)) (PP (IN on) (NP (NNP Lp)))) (VP (VBP are) (ADJP (JJ available)) (PP (IN in) (NP (DT the) (NN research) (CC and) (JJ lay) (NN press))))) (CC and) (S (NP (DT a) (NN book)) (VP (VBZ has) (VP (VBN been) (VP (VBN published) (PP (IN on) (NP (DT the) (NN topic))) (NP (DT this) (NN year)))))) (. .)))
6: (ROOT (S (NP (NP (DT A) (JJ unique) (NN feature)) (PP (IN of) (NP (NNP Lp)))) (VP (VBZ is) (SBAR (IN that) (, ,) (S (PP (IN in) (NP (NP (NN addition)) (PP (IN to) (NP (PRP$ its) (ADJP (ADJP (NN pr) (HYPH -) (JJ atherosclerotic)) (CC and) (ADJP (JJ pr) (HYPH -) (JJ inflammatory))) (NN potential))))) (, ,) (NP (PRP it)) (ADVP (RB also)) (VP (VBZ promotes) (NP (NN blood) (NN clotting)))))) (. .)))
7: (ROOT (S (NP (NNS Studies)) (VP (VBP have) (VP (VBN evaluated) (SBAR (IN if) (S (NP (NP (NNS persons)) (SBAR (WHNP (WP who)) (S (VP (VBP inherit) (NP (NNP Lp)))))) (VP (VBP are) (PP (IN at) (NP (NP (JJR more) (NN risk)) (PP (IN of) (NP (NP (NN blood) (NNS clots)) (PP (IN in) (NP (NP (DT the) (NNS legs)) (, ,) (NP (NNS lungs)) (CC and) (NP (JJ other) (NNS sites))))))))))))) (. .)))
8: (ROOT (S (NP (NP (DT An) (VBN increased) (NN frequency)) (PP (IN of) (NP (NNP Lp))) (PP (IN in) (NP (NP (NNS persons)) (VP (VBG suffering) (NP (DT these) (JJ serious) (NNS conditions)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported)))) (. .)))
9: (ROOT (S (NP (NP (DT An) (VBN elevated) (NN level)) (PP (IN of) (NP (NNP Lp))) (PP (IN in) (NP (NN stroke) (NNS patients)))) (VP (VBD increased) (NP (DT the) (NN risk)) (NP (CD 12) (NN fold)) (PP (IN for) (NP (DT a) (JJ deep) (JJ venous) (NN thrombosis))) (PP (IN in) (NP (CD one) (NN study)))) (. .)))
10: (ROOT (S (NP (NP (NP (CD COVI-19)) (CC and) (NP (NNP Hypercoagulability))) (NP (NP (DT An) (JJ unexpected) (NN aspect)) (PP (IN of) (NP (NN patient) (NN care))) (PP (IN during) (NP (NP (DT the) (JJ current) (NN pandemic)) (PP (IN with) (NP (HYPH COVI-19) (NNS infections))))))) (VP (VBZ is) (NP (NP (DT the) (JJ frequent) (NN finding)) (PP (IN of) (NP (NP (JJ aggressive) (NN blood) (NN clotting)) (PP (IN in) (NP (ADJP (JJ arterial) (CC and) (JJ venous)) (NNS circulations))))))) (. .)))
11: (ROOT (S (NP (DT A) (JJ unique) (NN coagulopathy)) (VP (VBZ has) (VP (VBN been) (VP (VP (VBN identified)) (CC and) (ADVP (RB recently)) (VP (VBN reviewed))))) (. .)))
12: (ROOT (S (NP (DT Some) (HYPH COVI-19) (NNS patients)) (VP (VP (VBP become) (ADJP (RB seriously) (JJ ill))) (CC and) (VP (VBP die) (PP (IN due) (IN to) (NP (NP (JJ rampant) (NN clotting)) (PP (IN in) (NP (JJ vital) (NNS organs))))))) (. .)))
13: (ROOT (S (NP (NP (NP (DT The) (JJ gripping) (NN fight)) (PP (IN for) (NP (NN survival))) (PP (IN by) (NP (NML (NNP Broadway) (NN star)) (NNP Nick) (NNP Cordero)))) (, ,) (CC and) (NP (PRP$ his) (NN need) (S (VP (TO to) (VP (VB have) (S (NP (DT a) (NN leg)) (VP (VBN amputated) (PP (ADVP (RB apparently)) (IN due) (PP (IN in) (NP (NN part))) (IN to) (NP (NP (JJ vascular) (NN compromise)) (CC and) (NP (NN clotting)))))))))) (, ,)) (VP (VBZ has) (VP (VBN captured) (NP (NP (JJ many) (NNS hearts) (CC and) (NNS minds)) (PP (IN in) (NP (DT the) (NNS media)))))) (. .)))
14: (ROOT (S (NP (NP (NN Lipoprotein)) (CC and) (NP (HYPH COVI-19))) (PP (IN To) (NP (NN date))) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (DT no) (VBN published) (NNS reports)) (VP (VBG examining) (SBAR (IN whether) (S (NP (NP (NNS levels)) (PP (IN of) (NP (NNP Lp)))) (VP (VBP are) (VP (VBN elevated) (PP (IN in) (NP (NP (NP (NNS patients)) (VP (VBG fighting) (NP (HYPH COVI-19)))) (SBAR (WHNP (WP who)) (S (VP (VBP experience) (NP (NN clotting) (NNS complications)))))))))))))) (. .)))
15: (ROOT (S (ADVP (RB However)) (, ,) (NP (CD two) (NNS organizations)) (VP (VBP have) (VP (VBN provided) (NP (NP (NNS comments)) (PP (IN on) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (DT this) (JJ possible) (NN connection)) (VP (MD should) (VP (VB be) (VP (VBN considered))))))))))) (. .)))
16: (ROOT (S (NP (DT The) (NNP FH) (NNP Foundation)) (VP (VBZ has) (VP (VBN added) (NP (NP (NP (DT a) (NN section)) (PP (IN on) (NP (PRP$ their) (NN website)))) (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (JJ many) (NNS patients)) (PP (IN with) (NP (NNP Familial) (NNP Hyperlipidemia)))) (ADVP (RB also)) (VP (VP (VBP have) (NP (DT an) (VBN elevated) (NNP Lp))) (CC and) (VP (MD may) (VP (VB be) (PP (IN at) (NP (NP (NN risk)) (PP (IN for) (NP (VBG clotting) (NNS disorders))))) (SBAR (IN if) (S (VP (VBN infected))))))))))))) (. .)))
17: (ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NNP Lipoprotein) (NNP Foundation)) (VP (VBZ has) (VP (VBN added) (NP (NNS comments)) (PP (IN on) (NP (PRP$ their) (NN website))))) (. .)))
18: (ROOT (S (NP (DT This)) (VP (VBD included) (NP (NP (DT a) (NN letter)) (PP (IN by)))) (. .)))
19: (ROOT (S (NP (PRP He)) (VP (VBZ indicates) (PP (IN in) (NP (DT the) (NN letter))) (SBAR (IN that) (S (NP (NP (DT an) (JJ inflammatory) (NN mediator)) (, ,) (NP (CD I-6)) (, ,)) (VP (VBZ is) (VP (VBN increased) (PP (IN in) (NP (NP (DT the) (NN cytokine) (NN storm)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB develop) (PP (IN during) (NP (DT a) (CD COVI-19) (NN infection)))))))))))))) (. .)))
20: (ROOT (S (NP (HYPH I-6)) (VP (MD can) (ADVP (RB also)) (VP (VB increase) (NP (NP (NNS levels)) (PP (IN of) (NP (NNP Lp)))) (S (VP (VBG raising) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (ADJP (VBN elevated) (CC and) (VBG rising)) (NNS levels)) (PP (IN of) (NP (NNP Lp)))) (VP (MD could) (VP (VB lead) (PP (IN to) (NP (NP (JJ cardiovascular) (NNS complications)) (CC and) (NP (DT a) (JJR poorer) (NN prognosis))))))))))))) (. .)))
21: (ROOT (SBARQ (WHNP (WP What)) (S (VP (TO to) (VP (VB Do)))) (. ?)))
22: (ROOT (S (SBAR (IN If) (S (NP (PRP you)) (VP (VBP know) (SBAR (S (NP (PRP you)) (VP (VBP have) (NP (NP (DT an) (VBN elevated) (NN level)) (PP (IN of) (NP (NNP Lp)))))))))) (, ,) (NP (NP (PRP it))) (VP (MD would) (VP (VB seem) (S (ADJP (JJ prudent))) (S (VP (TO to) (VP (VB take) (NP (ADJP (RB even) (JJR greater)) (NNS precautions)) (PP (IN with) (NP (NP (NN hand) (NN washing)) (, ,) (NP (JJ physical) (NN distancing)) (, ,) (NP (NNS masks)) (, ,) (CC and) (NP (NP (ADJP (RB overall) (JJ healthy)) (NNS lifestyles)) (PP (VBG including) (NP (ADJP (NN nutrient) (JJ rich)) (NNS diets))))))))))) (. .)))
23: (ROOT (S (SBAR (IN If) (S (NP (PRP you)) (VP (VBP do) (RB not) (VP (VB know) (SBAR (IN if) (S (NP (PRP you)) (VP (VBP have) (NP (DT an) (VBN elevated) (NN level))))))))) (, ,) (NP (NP (PRP it))) (VP (MD would) (VP (VB be) (ADJP (JJ wise)) (S (VP (TO to) (VP (VB have) (S (NP (PRP yours)) (VP (VBN checked) (PP (IN on) (NP (NP (DT a) (JJ simple) (NN blood) (NN test)) (VP (VBN run) (PP (IN by) (NP (DT every) (JJ major) (NN laboratory))))))))))))) (. .)))
24: (ROOT (S (NP (EX There)) (VP (VBZ is) (ADVP (RB even)) (NP (NP (NP (DT a) (HYPH IC-10) (NN code)) (PP (IN for) (NP (JJ elevated) (NNP Lp)))) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (CD E78.41))))))) (. .)))
25: (ROOT (S (SBAR (IN If) (S (NP (PRP you)) (VP (VBP have) (NP (JJ cardiovascular) (NN disease))))) (, ,) (S (VP (VBG taking) (NP (NNS precautions)) (PP (IN as) (PP (IN to) (NP (NN exposure) (CC and) (NN lifestyle)))))) (VP (VBP are) (VP (VBN recommended) (PP (IN along) (PP (IN with) (S (VP (VBG maintaining) (NP (PRP$ your) (NN prescription) (NNS medications)))))))) (. .)))
26: (ROOT (S (NP (NP (PRP It))) (VP (VBZ is) (ADJP (JJ unknown)) (SBAR (IN if) (S (VP (VBN added) (NP (DT a) (NML (JJ low) (NN dose)) (JJ adult) (NN aspirin)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT an) (NN allergy)))))) (, ,) (CC or) (VP (VBG using) (NP (NP (JJ natural) (NNS anticoagulants)) (PP (IN like) (NP (NN garlic) (CC and) (NN nattokinase))))) (, ,) (VP (VBP are) (PP (IN of) (NP (DT any) (NN protection)))))))))
